# Use of the Guardian™ Connect System With Smart Connected Devices

> **NCT04809285** · NA · COMPLETED · sponsor: **Medtronic MiniMed, Inc.** · enrollment: 217 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Guardian™ Connect system, InPen™ Basal smart cap, smart insulin pens, and InPen™ Diabetes Management app

## Key facts

- **NCT ID:** NCT04809285
- **Lead sponsor:** Medtronic MiniMed, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-06
- **Primary completion:** 2023-09-29
- **Final completion:** 2023-09-29
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04809285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04809285, "Use of the Guardian™ Connect System With Smart Connected Devices". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04809285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*